Polygenic growth scores help identify fetuses at risk for LGA birth weight, particularly in mothers with a BMI of 35 or higher.

Women benefit from planning before conception ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

Ashlee Black always knew her daughter was special, but didn’t know exactly how special. The 36-year-old tells PEOPLE it wasn't until her daughter, Valyn, was 4 weeks old that she noticed the little ...

Repair of open neural tube defects, including myelomeningocele, in the fetus has been shown to improve postnatal outcomes by decreasing the severity of hydrocephalus and, consequentially, reducing the ...

A first in-human, phase I trial examined feasibility as well as safety ...

The mom tells PEOPLE she believes her daughter has chimerism, a rare condition in which a single individual possesses at least two distinct sets of DNA Ashlee Black's daughter was born with "different ...

Introduction Implementing shared decision-making (SDM) in maternity care remains challenging in low-income and middle-income ...

New indications expand treatment options for appropriate children aged 2.5 years and older with Idiopathic Short Stature (ISS), born Small for Gestational ...

A machine-learning model developed by Weill Cornell Medicine investigators may provide clinicians with an early warning of a ...

The FDA has approved three new pediatric indications for somapacitan-beco, a once-weekly, long-acting growth hormone injection, according to a press release issued by Novo Nordisk.Somapacitan-beco ...